Ropinirole in restless legs syndrome and periodic limb movement disorder

Review

(2082) Views  (669) Full article downloads

Authors: Daniel Erichsen, Raffaelle Ferri, David Gozal

Published Date April 2010 Volume 2010:6 Pages 173 - 182

DOI: http://dx.doi.org/10.2147/TCRM.S6717

Daniel Erichsen¹, Raffaelle Ferri², David Gozal¹

¹Department of Pediatrics, University of Chicago, Chicago, IL, USA; ²Department of Neurology, Oasi Institute IRCCS, Troina, Italy

Abstract: Restless legs syndrome and periodic limb movement disorder of sleep are now recognized as prevalent, distinct, yet overlapping disorders affecting all age groups. Although delineation of the mechanisms underlying these disorders continues to be the focus of very intense research efforts, it has become apparent that there is a prominent role for dopaminergic agents in the clinical management of these patients. Among the various dopaminergic drugs, ropinirole has undergone relatively intense and critical scrutiny, and appears to provide a safe and efficacious treatment option for patients with these two conditions. The more recent development of a controlled formulation for this drug is likely to yield additional benefits such as improved adherence and reduced fluctuations in daytime and nighttime symptoms. However, there is not enough evidence at this time to support such assumption.

Keywords: dopaminergic drugs, restless legs syndrome, ropinirole, period limb movement disorder

Readers of this article also read: